GlassScriptPhysician profile
Carl D Bechtold
NPI 1336160589
$7,474.50
in general payments reported to CMS, 2019-2025
12 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,179 · 2020: $2,326 · 2021: $1,307 · 2022: $1,369 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $3,809.75 | 2019-2022 | |
| Kci USA, INC. | $2,024.68 | 2019-2021 | |
| Stryker Corporation | $1,023.37 | 2020 | |
| Medical Device Business Services, INC. | $226.96 | 2020-2022 | |
| Medtronic, INC. | $161.85 | 2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Davol INC. | $66.34 | 2025 | Arista |
| Access Pro Medical, LLC | $66.34 | 2025 | Matriderm |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Bioventus LLC | $20.97 | 2019 | |
| Pacira Therapeutics, INC. | $17.42 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.73 | 2019 | |
| Convatec INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Bechtold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.